Navigation Links
The Montreal Heart Institute presents findings on congestive heart failure and atrial fibrillation
Date:6/19/2008

The results of a major international clinical trial coordinated by the Montreal Heart Institute were reported today in the New England Journal of Medicine. The Atrial Fibrillation and Congestive Heart Failure Trial (AF-CHF) was a prospective, multicentre project involving patients with heart failure and atrial fibrillation. Heart failure is an important cause of death in the population and associated atrial fibrillation (a very common heart rhythm disorder) further increases the risks. The trial was launched in 2001 and enrolled 1,376 patients at 123 hospital sites in North America, South America, Europe and Israel. The project's goal was to improve treatment with the objective of reducing mortality and morbidity linked with atrial fibrillation and heart failure. Made possible by a grant of more than $6.5 million from the Canadian Institutes of Health Research (CIHR), this study was directed by Dr. Denis Roy, a cardiologist at the Montreal Heart Institute (MHI) and Chair of the Department of Medicine at the Universit de Montral, in collaboration with Dr. Mario Talajic, also a cardiologist at the MHI, and several Canadian researchers and international experts who contributed to this large-scale research project.

Methodology

Between May 2001 and June 2005, the 1,376 patients were randomly assigned to a rhythm-control strategy (where patients received electrical shocks and medication to suppress the abnormal rhythm) or a more simpler strategy of rate-control (where two common drugs, beta-blockers and digitalis, are used to prevent rapid heart rates with no specific efforts to regularize the rhythm). The primary endpoint of the study was cardiovascular mortality. Data management and analysis were performed at the Montreal Heart Institute Coordinating Center (MHICC).

Rate-control as effective as rhythm-control

The intention-to-treat analysis revealed no difference in the primary endpoint between the two groups.
'/>"/>

Contact: Valrie Gonzalo
gonzalo@videotron.ca
514-626-6976
University of Montreal
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. World fertility experts to meet in Montreal - IVF and IVM patients to provide first-person accounts at 14th World Congress
2. Worrell Inc. Acquires Gad Shaanan Design Operations in Montreal and San Diego
3. The Montreal Childrens Hospital of the MUHC begins search for causes of autism
4. Haemacure to Present at Busines$ Meets Finance on May 20, 2008 at the Montreal Sheraton Centre
5. Drug for cluster headaches may cause heart problems
6. Use of certain lipid measures not more effective in predicting coronary heart disease
7. Restricting Blood Flow May Help Heart Bypass Patients
8. Urban Smog Tough on Young Adults Hearts
9. Stanford study highlights cost-effective method of lowering heart disease risks
10. Vitamin Es lack of heart benefit linked to dosage
11. Drug That Lowers Resting Heart Rate Being Tested
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... Foot and Ankle ... new associate podiatrist, creating the largest medical practice in the Mid-Atlantic region – and ... FASMA operates 21 locations with 33 doctors. , Dr. Hetal Kathrotiya-Mago is a Maryland ...
(Date:8/2/2015)... ... August 03, 2015 , ... Career Step, an online institution ... Association for Healthcare Documentation Integrity’s (AHDI) conference being held in Alexandria, Virginia, on ... the AHDI conference provides us to interact with those in the healthcare documentation ...
(Date:8/1/2015)... In (PRWEB) , ... August 02, 2015 , ... ... month which will help the continuity of care for patients at this natural health ... of the unknown," Clinic Director Mary Heal said. "Heather's role is vital to our ...
(Date:8/1/2015)... ... August 01, 2015 , ... Calvary Hospital today announced that it is embarking ... The goal is to bring this Torah – dating from 1880 – back to ... religious services. , Scroll No. 515, from the town of Taus-Domazlice, is on ...
(Date:8/1/2015)... ... August 01, 2015 , ... Lume Wellness creators Alex, Robert, ... to download on the Apple AppStore. , The app is designed to track ... acting as a tool to view personal health and use this information for positive ...
Breaking Medicine News(10 mins):Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 2Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 3Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 4Health News:Career Step to Exhibit at AHDI Conference in Alexandria, Virginia on August 7-8 2Health News:New Patient Advocate Enhances Natural Health Care 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 3Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2
... are the top among nuts and seeds that contain ... cholesterol levels and improves heart health, according to a ... University analysed some 27 nut and seed products in ... to date, science portal EurekAlert reported. ,They found ...
... institution, Lasik, the eye surgery that corrects vision be means ... An average procedure costs somewhere between $3,000 to $5,000 and ... are still question marks over the efficacy of the treatment ... that over 18 percent of the people require a second ...
... Professor Stanley Finger of Washington University writes in his ... Benjamin Franklin who has been a great scientist, inventor, ... any formal medical education has contributed a lot to ... practicing medicine in America during the 18th Century in ...
... that being a misfit in her group kept her away from ... further insisted that perhaps her dislike of living in the fast ... she was younger. ,I missed out on the whole ... in my life. I've never taken coke, Femalefirst quoted her, as ...
... Hormone is chanted as the new anti-ageing mantra. The ... (HGH) therapy has found some positive results. // ... have something here which may be able to reverse ... from Denmark state, Replacement therapy with Growth Hormone has ...
... the Australian Nobel Prize winners for medicine received their awards ... Stockholm yesterday. // ,The Nobel Committe was ... concept. Professor Marshall and Dr Warren were of the opinion ... stress or lifestyle changes as previously believed. To prove this ...
Cached Medicine News:Health News:LASIK Treatments Still To Reach Common Man 2
(Date:7/31/2015)... 31, 2015 Egalet Corporation (Nasdaq: ... company focused on developing, manufacturing and marketing innovative ... previously announced underwritten public offering of 7,666,667 shares ... price of $11.25 per share. The shares of ... issued upon the exercise in full by the ...
(Date:7/31/2015)... WOODCLIFF LAKE, N.J. and SAN ... announced today that its parent company Eisai Co., Ltd. ... Haruo Naito , "Eisai") and Halozyme Therapeutics, Inc. ... and CEO: Dr. Helen Torley , "NASDAQ: HALO") ... eribulin mesylate (brand name: Halaven ® , "eribulin") in ...
(Date:7/31/2015)... According to a new market research report ... Dual-Energy X-ray Absorptiometry (DEXA), Skinfold Calipers, Air Displacement Plethysmography ... to 2019", published by MarketsandMarkets, the global Body Composition ... is estimated to grow to $1,425.7 Million by 2019, ... 2019. Browse 41 market data Tables ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4
... in high performance ultrasound design provides ... echocardiography. Echocardiography imaging requires superior spatial ... Doppler performance. The Terason Echo Ultrasound ... Architecture, delivers a compact imaging platform ...
... the first intra-operative fluorescent imaging system ... the location of the coronary arteries ... coronary artery bypass procedures. ,The patented ... to view, record, replay, print, and ...
... the ingestible SmartPill pH.p Capsule passes through the ... power RF carrier frequencies to the SmartPill Data ... is worn by the patient (supported by either ... records pressure, temperature and pH measurement data, and ...
... light source offers the industry standard high intensity ... at a lower price. A universal turret on ... be used with Olympus, Storz, ACMI/Circon and Wolf ... and re-settable bulb timer. The White Sun will ...
Medicine Products: